(CHWY) Chewy - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US16679L1098
Food, Treats, Supplies, Medications, Services
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 48.9% |
| Value at Risk 5%th | 73.8% |
| Relative Tail Risk | -8.22% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.15 |
| Alpha | -11.02 |
| CAGR/Max DD | -0.09 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.467 |
| Beta | 0.790 |
| Beta Downside | 0.854 |
| Drawdowns 3y | |
|---|---|
| Max DD | 69.66% |
| Mean DD | 37.15% |
| Median DD | 33.15% |
Description: CHWY Chewy October 30, 2025
Chewy, Inc. (NYSE:CHWY) operates an U.S.-focused e-commerce platform that sells pet food, treats, supplies, medications, and related health products, and it also provides pet services through its website and mobile apps, notably its Autoship subscription program. Founded in 2010 and headquartered in Plantation, Florida, Chewy is classified under the “Other Specialty Retail” sub-industry.
Key recent metrics: Q3 2024 net revenue grew 12% year-over-year to $2.1 billion, driven by a 15% increase in active customers and a 9% rise in average order value. The company’s subscription base now represents roughly 38% of total sales, enhancing revenue predictability. Macro-level, discretionary spending trends and rising pet-ownership rates (currently ~70% of U.S. households) remain core growth levers for the pet-care e-commerce sector.
For a deeper quantitative dive, the ValueRay platform offers up-to-date metrics and scenario analyses on CHWY.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (151.1m TTM) > 0 and > 6% of Revenue (6% = 740.7m TTM) |
| FCFTA 0.15 (>2.0%) and ΔFCFTA 6.52pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -3.33% (prev -2.67%; Δ -0.67pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.20 (>3.0%) and CFO 611.3m > Net Income 151.1m (YES >=105%, WARN >=100%) |
| Net Debt (-97.7m) to EBITDA (332.9m) ratio: -0.29 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.81 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (428.4m) change vs 12m ago -2.17% (target <= -2.0% for YES) |
| Gross Margin 29.45% (prev 28.97%; Δ 0.48pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 396.9% (prev 365.2%; Δ 31.72pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 35.37 (EBITDA TTM 332.9m / Interest Expense TTM 5.16m) >= 6 (WARN >= 3) |
Altman Z'' -2.55
| (A) -0.13 = (Total Current Assets 1.78b - Total Current Liabilities 2.19b) / Total Assets 3.12b |
| (B) -0.47 = Retained Earnings (Balance) -1.46b / Total Assets 3.12b |
| (C) 0.06 = EBIT TTM 182.7m / Avg Total Assets 3.11b |
| (D) -0.53 = Book Value of Equity -1.45b / Total Liabilities 2.73b |
| Total Rating: -2.55 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 84.35
| 1. Piotroski 7.0pt |
| 2. FCF Yield 3.28% |
| 3. FCF Margin 3.75% |
| 4. Debt/Equity 1.27 |
| 5. Debt/Ebitda -0.29 |
| 6. ROIC - WACC (= 40.33)% |
| 7. RoE 48.34% |
| 8. Rev. Trend 95.21% |
| 9. EPS Trend 67.72% |
What is the price of CHWY shares?
As of December 04, 2025, the stock is trading at USD 33.95 with a total of 5,063,378 shares traded.
Over the past week, the price has changed by -0.79%, over one month by +3.13%, over three months by -16.69% and over the past year by +0.98%.
Over the past week, the price has changed by -0.79%, over one month by +3.13%, over three months by -16.69% and over the past year by +0.98%.
Is CHWY a buy, sell or hold?
Chewy has received a consensus analysts rating of 3.90.
Therefore, it is recommended to buy CHWY.
- Strong Buy: 11
- Buy: 6
- Hold: 12
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the CHWY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 45.1 | 32.7% |
| Analysts Target Price | 45.1 | 32.7% |
| ValueRay Target Price | 32.9 | -3.1% |
CHWY Fundamental Data Overview November 29, 2025
Market Cap USD = 14.20b (14.20b USD * 1.0 USD.USD)
P/E Trailing = 95.0556
P/E Forward = 25.3165
P/S = 1.1498
P/B = 36.4071
P/EG = 1.3134
Beta = 1.591
Revenue TTM = 12.35b USD
EBIT TTM = 182.7m USD
EBITDA TTM = 332.9m USD
Long Term Debt = 494.1m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 33.5m USD (from shortTermDebt, last fiscal year)
Debt = 494.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -97.7m USD (from netDebt column, last quarter)
Enterprise Value = 14.10b USD (14.20b + Debt 494.1m - CCE 591.8m)
Interest Coverage Ratio = 35.37 (Ebit TTM 182.7m / Interest Expense TTM 5.16m)
FCF Yield = 3.28% (FCF TTM 463.0m / Enterprise Value 14.10b)
FCF Margin = 3.75% (FCF TTM 463.0m / Revenue TTM 12.35b)
Net Margin = 1.22% (Net Income TTM 151.1m / Revenue TTM 12.35b)
Gross Margin = 29.45% ((Revenue TTM 12.35b - Cost of Revenue TTM 8.71b) / Revenue TTM)
Gross Margin QoQ = 30.35% (prev 29.65%)
Tobins Q-Ratio = 4.52 (Enterprise Value 14.10b / Total Assets 3.12b)
Interest Expense / Debt = 0.24% (Interest Expense 1.19m / Debt 494.1m)
Taxrate = 16.22% (12.0m / 74.0m)
NOPAT = 153.1m (EBIT 182.7m * (1 - 16.22%))
Current Ratio = 0.81 (Total Current Assets 1.78b / Total Current Liabilities 2.19b)
Debt / Equity = 1.27 (Debt 494.1m / totalStockholderEquity, last quarter 389.9m)
Debt / EBITDA = -0.29 (Net Debt -97.7m / EBITDA 332.9m)
Debt / FCF = -0.21 (Net Debt -97.7m / FCF TTM 463.0m)
Total Stockholder Equity = 312.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.85% (Net Income 151.1m / Total Assets 3.12b)
RoE = 48.34% (Net Income TTM 151.1m / Total Stockholder Equity 312.6m)
RoCE = 22.64% (EBIT 182.7m / Capital Employed (Equity 312.6m + L.T.Debt 494.1m))
RoIC = 48.96% (NOPAT 153.1m / Invested Capital 312.6m)
WACC = 8.64% (E(14.20b)/V(14.69b) * Re(8.93%) + D(494.1m)/V(14.69b) * Rd(0.24%) * (1-Tc(0.16)))
Discount Rate = 8.93% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.27%
[DCF Debug] Terminal Value 76.75% ; FCFE base≈381.1m ; Y1≈423.8m ; Y5≈555.9m
Fair Price DCF = 36.45 (DCF Value 8.20b / Shares Outstanding 225.1m; 5y FCF grow 12.91% → 3.0% )
EPS Correlation: 67.72 | EPS CAGR: 138.4% | SUE: -4.0 | # QB: 0
Revenue Correlation: 95.21 | Revenue CAGR: 9.45% | SUE: 1.35 | # QB: 3
EPS next Year (2027-01-31): EPS=1.51 | Chg30d=-0.004 | Revisions Net=+0 | Growth EPS=+18.6% | Growth Revenue=+8.1%
P/E Trailing = 95.0556
P/E Forward = 25.3165
P/S = 1.1498
P/B = 36.4071
P/EG = 1.3134
Beta = 1.591
Revenue TTM = 12.35b USD
EBIT TTM = 182.7m USD
EBITDA TTM = 332.9m USD
Long Term Debt = 494.1m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 33.5m USD (from shortTermDebt, last fiscal year)
Debt = 494.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -97.7m USD (from netDebt column, last quarter)
Enterprise Value = 14.10b USD (14.20b + Debt 494.1m - CCE 591.8m)
Interest Coverage Ratio = 35.37 (Ebit TTM 182.7m / Interest Expense TTM 5.16m)
FCF Yield = 3.28% (FCF TTM 463.0m / Enterprise Value 14.10b)
FCF Margin = 3.75% (FCF TTM 463.0m / Revenue TTM 12.35b)
Net Margin = 1.22% (Net Income TTM 151.1m / Revenue TTM 12.35b)
Gross Margin = 29.45% ((Revenue TTM 12.35b - Cost of Revenue TTM 8.71b) / Revenue TTM)
Gross Margin QoQ = 30.35% (prev 29.65%)
Tobins Q-Ratio = 4.52 (Enterprise Value 14.10b / Total Assets 3.12b)
Interest Expense / Debt = 0.24% (Interest Expense 1.19m / Debt 494.1m)
Taxrate = 16.22% (12.0m / 74.0m)
NOPAT = 153.1m (EBIT 182.7m * (1 - 16.22%))
Current Ratio = 0.81 (Total Current Assets 1.78b / Total Current Liabilities 2.19b)
Debt / Equity = 1.27 (Debt 494.1m / totalStockholderEquity, last quarter 389.9m)
Debt / EBITDA = -0.29 (Net Debt -97.7m / EBITDA 332.9m)
Debt / FCF = -0.21 (Net Debt -97.7m / FCF TTM 463.0m)
Total Stockholder Equity = 312.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.85% (Net Income 151.1m / Total Assets 3.12b)
RoE = 48.34% (Net Income TTM 151.1m / Total Stockholder Equity 312.6m)
RoCE = 22.64% (EBIT 182.7m / Capital Employed (Equity 312.6m + L.T.Debt 494.1m))
RoIC = 48.96% (NOPAT 153.1m / Invested Capital 312.6m)
WACC = 8.64% (E(14.20b)/V(14.69b) * Re(8.93%) + D(494.1m)/V(14.69b) * Rd(0.24%) * (1-Tc(0.16)))
Discount Rate = 8.93% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.27%
[DCF Debug] Terminal Value 76.75% ; FCFE base≈381.1m ; Y1≈423.8m ; Y5≈555.9m
Fair Price DCF = 36.45 (DCF Value 8.20b / Shares Outstanding 225.1m; 5y FCF grow 12.91% → 3.0% )
EPS Correlation: 67.72 | EPS CAGR: 138.4% | SUE: -4.0 | # QB: 0
Revenue Correlation: 95.21 | Revenue CAGR: 9.45% | SUE: 1.35 | # QB: 3
EPS next Year (2027-01-31): EPS=1.51 | Chg30d=-0.004 | Revisions Net=+0 | Growth EPS=+18.6% | Growth Revenue=+8.1%
Additional Sources for CHWY Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle